Two Sigma Advisers’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $312K | Buy |
|
|||||
|
2025
Q1 | $163K | Sell |
|
|||||
|
2024
Q4 | $779K | Sell |
|
|||||
|
2024
Q3 | $1.33M | Sell |
|
|||||
|
2024
Q2 | $1.53M | Buy |
|
|||||
|
2024
Q1 | $236K | Sell |
|
|||||
|
2023
Q4 | $552K | Sell |
|
|||||
|
2023
Q3 | $214K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $228K | Sell |
|
|||||
|
2022
Q4 | $300K | Buy |
|
|||||
|
2022
Q3 | $267K | Sell |
|
|||||
|
2022
Q2 | $284K | Sell |
|
|||||
|
2022
Q1 | $491K | Sell |
|
|||||
|
2021
Q4 | $747K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $234K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $69K | Sell |
|
|||||
|
2014
Q3 | $105K | Buy |
|